Concepedia

James Atherton

JA

11

Publications

672

Citations

11

H-Index

1999

Active since

Affiliations

Pfizer (United States)(Current)

James Atherton is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1999–2020

11

Publications

11

Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451

W. Gregory Roberts, Pamela Whalen, Erik Soderstrom et al. · Cancer Research · 2005 · 135 citations · Full text

Inhibition of Hepatobiliary Transport as a Predictive Method for Clinical Hepatotoxicity of Nefazodone

Seva E. Kostrubsky, Stephen C. Strom, Amit S. Kalgutkar et al. · Toxicological Sciences · 2006 · 120 citations · Full text

Biotransformation: Impact and Application of Metabolism in Drug Discovery

Julia Shanu-Wilson, Liam Evans, Stephen K. Wrigley et al. · ACS Medicinal Chemistry Letters · 2020 · 99 citations · Full text

Determination of Degradation Pathways and Kinetics of Acyl Glucuronides by NMR Spectroscopy

Gregory S. Walker, James Atherton, Jonathan Bauman et al. · Chemical Research in Toxicology · 2007 · 67 citations

, , +19

P2Y1 receptor antagonists as novel antithrombotic agents

Jeffrey A. Pfefferkorn, Chulho Choi, Thomas Winters et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 51 citations · Full text

, , +8

Rows per page

1–5 of 11